GLP-1 cost control is pulling against the need for continuous member support.
Pharmacy leaders need accountable utilization, while population-health leaders need a care path that members will enter and sustain.
Who you’d be doing this for
“My pharmacy team asks where the savings are, and members ask who helps after the prescription.”
Marina Carvalho · Population Health Manager
Leads cardiometabolic programs for a regional health plan whose members are beginning GLP-1 therapy.
What is at stake
Health-plan members beginning GLP-1 therapy are receiving disconnected support across pharmacy and behavior resources. You have to weigh a faster referral path against clinical clarity, contracting fit, and a credible outcomes commitment.
Why it isn’t already fixed
Every obvious fix costs something else. That’s the part you’d have to decide.
- GLP-1 cost control vs continuous member support
- faster channel entry vs clinically precise promise
- plan simplicity vs differentiated referral model
- commercial repeatability vs partner-specific requirements
Why Sword Health
Pulse combines GLP-1 support with continuous cardiometabolic care, giving health plans a route beyond disconnected pharmacy resources.
Written with these in mind
Not your kind of problem? 30 more at Sword Health, or browse every organization.
This is the setup. The work is inside.
Running it puts you in the room: the full situation and its constraints, stakeholders who push back in their own words, and the decisions that are yours to make. What you produce becomes a Day One Plan — work you can show someone instead of describing.